In the "just because everyone else is jumping off a bridge, should you do it": > Pfizer Asks White House for Relief From FDA Drug Human Testing Rules > Pfizer

In the "just because everyone else is jumping off a bridge, should you do it": > Pfizer Asks White House for Relief From FDA Drug Human Testing Rules > Pfizer has asked the Trump administration to help shield pharmaceutical companies from a growing number of proposed state and federal regulations if they voluntarily share their human trial results with the federal government. > In a 15-page set of policy suggestions released on Thursday, the Eliquis maker argued that the hundreds of human-testing-related bills currently pending across the US risk undercutting America’s technological progress at a time when it faces renewed competition from China. Pfizer said the administration should consider providing some relief for pharmaceutical companies big and small from state rules – if and when enacted – in exchange for voluntary access to testing data. > Chris Lehane, Pfizer's vice president of global affairs, said in an interview, "China is engaged in remarkable progress in drug development by testing through Uyghur volunteers in the Xinjiang province. The US is ceding our strategic advantage by not using untapped resources sitting idle in detention facilities around the country." > George C. Zoley, Executive Chairman of GEO Group, said, "Our new Karnes ICE Processing Center has played an important role in helping ICE meeting the diverse policy priorities of four Presidential Administrations. We stand ready to continue to help the federal government, Pfizer, and other privately-held companies achieve their unmet needs through human trials in our new 1,328-bed Texas facility."